title: A second locus for Aicardi-Goutieres syndrome at chromosome 13q14-21.
abstract: BACKGROUND
  Aicardi-Goutières syndrome (AGS) is an autosomal recessive, early onset encephalopathy characterised by calcification of the basal ganglia, chronic cerebrospinal fluid lymphocytosis, and negative serological investigations for common prenatal infections. AGS may result from a perturbation of interferon alpha metabolism. The disorder is genetically heterogeneous with approximately 50% of families mapping to the first known locus at 3p21 (AGS1).
  
  
  METHODS
  A genome-wide scan was performed in 10 families with a clinical diagnosis of AGS in whom linkage to AGS1 had been excluded. Higher density genotyping in regions of interest was also undertaken using the 10 mapping pedigrees and seven additional AGS families.
  
  
  RESULTS
  Our results demonstrate significant linkage to a second AGS locus (AGS2) at chromosome 13q14-21 with a maximum multipoint heterogeneity logarithm of the odds (LOD) score of 5.75 at D13S768. The AGS2 locus lies within a 4.7 cM region as defined by a 1 LOD-unit support interval.
  
  
  CONCLUSIONS
  We have identified a second AGS disease locus and at least one further locus. As in a number of other conditions, genetic heterogeneity represents a significant obstacle to gene identification in AGS. The localisation of AGS2 represents an important step in this process.
authors.affiliation: Molecular Medicine Unit, University of Leeds, St James's University Hospital, Leeds, UK.
authors.forename: M
authors.initials: M
authors.lastname: Ali
authors.forename: L J
authors.initials: LJ
authors.lastname: Highet
authors.forename: D
authors.initials: D
authors.lastname: Lacombe
authors.forename: C
authors.initials: C
authors.lastname: Goizet
authors.forename: M D
authors.initials: MD
authors.lastname: King
authors.forename: U
authors.initials: U
authors.lastname: Tacke
authors.forename: M S
authors.initials: MS
authors.lastname: van der Knaap
authors.forename: L
authors.initials: L
authors.lastname: Lagae
authors.forename: C
authors.initials: C
authors.lastname: Rittey
authors.forename: H G
authors.initials: HG
authors.lastname: Brunner
authors.forename: H
authors.initials: H
authors.lastname: van Bokhoven
authors.forename: B
authors.initials: B
authors.lastname: Hamel
authors.forename: Y A
authors.initials: YA
authors.lastname: Oade
authors.forename: A
authors.initials: A
authors.lastname: Sanchis
authors.forename: I
authors.initials: I
authors.lastname: Desguerre
authors.forename: D
authors.initials: D
authors.lastname: Cau
authors.forename: N
authors.initials: N
authors.lastname: Mathieu
authors.forename: M L
authors.initials: ML
authors.lastname: Moutard
authors.forename: P
authors.initials: P
authors.lastname: Lebon
authors.forename: D
authors.initials: D
authors.lastname: Kumar
authors.forename: A P
authors.initials: AP
authors.lastname: Jackson
authors.forename: Y J
authors.initials: YJ
authors.lastname: Crow
mesh_terms: D001480:Basal Ganglia Diseases / Q000175:diagnosis / Q000235:genetics*; D002114:Calcinosis / Q000175:diagnosis / Q000235:genetics*; D002874:Chromosome Mapping; D002882:Chromosomes, Human, Pair 13; D015331:Cohort Studies; D003241:Consanguinity; D005260:Female; D005808:Genes, Recessive; D008040:Genetic Linkage; D005838:Genotype; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008218:Lymphocytosis / Q000175:diagnosis / Q000235:genetics*; D008297:Male; D013577:Syndrome